Active Ingredients Used in Antibacterial Soaps – U.S. Food and Drug Administration issue final rule

The U.S. Food and Drug Administration (FDA) on the 2nd September 2016, issued a final rule banning certain active ingredients used in antibacterial soaps and related products marketed to consumers or made available for use in public areas, within the United States.

These products are intended for use with water, and are rinsed off after use.

This rule does not affect consumer hand “sanitizers” or wipes, or antibacterial products used in health care settings. This final rule applies to consumer antibacterial soap products containing one or more of 19 specific active ingredients, including Triclosan – one of the most commonly used ingredients.

Designed to provide a smooth transition for manufacturers and suppliers, manufacturers of these active ingredients in antibacterial soaps, have one year to comply with this rule by reformulating or removing these products from the market.

How will this ruling on antibacterial soaps affect existing products?

In anticipation of this new FDA ruling, Vectair Systems has already reformulated and tested its new Antibacterial soap for their Vectair Sanitex™ MVP antibacterial soaps offering, for an imminent and seamless production transition. This quick and decisive reaction to the new FDA ruling underlines Vectair Systems professional commitment to develop safe, sustainable, innovative and high performance product solutions.

Vectair Systems continues to offer a full hand hygiene product portfolio that meets FDA requirements. As an industry leader, Vectair Systems is dedicated to consistently develop scientific and innovative hygiene product solutions.